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Abstract
Objectives To assess whether initial or 12–18-month change in magnetic resonance imaging (MRI) subchondral bone texture is
predictive of radiographic knee osteoarthritis (OA) progression over 36 months.
Methods This was a nested case-control study including 122 knees/122 participants in the Osteoarthritis Initiative (OAI) Bone
Ancillary Study, who underwent MRI optimised for subchondral bone assessment at either the 30- or 36-month and 48-month
OAI visits. Case knees (n = 61) had radiographic OA progression between the 36- and 72-month OAI visits, defined as ≥ 0.7 mm
minimum medial tibiofemoral radiographic joint space (minJSW) loss. Control knees (n = 61) without radiographic OA pro-
gression were matched (1:1) to cases for age, sex, body mass index and initial medial minJSW. Texture analysis was performed
on the medial femoral and tibial subchondral bone. We assessed the association of texture features with radiographic progression
by creating a composite texture score using penalised logistic regression and calculating odds ratios. We evaluated the predictive
performance of texture features for predicting radiographic progression using c-statistics.
Results Initial (odds ratio [95% confidence interval] = 2.13 [1.41–3.40]) and 12– 18-month change (3.76 [2.04–7.82]) texture
scores were significantly associated with radiographic OA progression. Combinations of texture features were significant
predictors of radiographic progression using initial (c-statistic [95% confidence interval] = 0.65 [0.64–0.65], p = 0.003) and
12–18-month change (0.68 [0.68-0.68], p < 0.001) data.
Conclusions Initial and 12–18-month changes in MRI subchondral bone texture score were significantly associated with radio-
graphic progression at 36 months, with better predictive performance for 12–18-month change in texture. These results suggest
that texture analysis may be a useful biomarker of subchondral bone in OA.
Key Points
• Subchondral bone MRI texture analysis is a promising knee osteoarthritis imaging biomarker.
• In this study, subchondral bone texture was associated with knee osteoarthritis progression.
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• This demonstrates predictive and concurrent validity of MRI subchondral bone texture analysis.
• This method may be useful in clinical trials with interventions targeting bone.
Keywords Osteoarthritis, knee .Magnetic resonance imaging . Case-control studies . Logistic models
Abbreviations
BAS Bone Ancillary Study
OAI Osteoarthritis Initiative
minJSW Minimum (medial tibiofemoral) joint space width
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Introduction
It is increasingly recognised that subchondral bone plays a
critical role in osteoarthritis (OA) onset and progression.
Subchondral bone is a dynamic tissue, absorbing the majority
of forces transmitted through the joint and capable of remod-
elling in response to stress [1]. Therefore, there has been in-
creasing interest in subchondral bone as a target for potential
disease-modifying OA drugs (DMOADs) [2].
Sensitive markers of subchondral bone alterations that oc-
cur in OA are required for such treatments to be evaluated.
Several imaging biomarkers of subchondral bone have been
described using plain radiographs, dual x-ray absorptiometry
(DXA), computed tomography (CT) and magnetic resonance
imaging (MRI), including direct estimation of trabecular
microarchitecture and fractal signature analysis (FSA) [3, 4].
While several established biomarkers have shown cross-
sectional associations with OA severity, there remains room
for improvement with regard to the ability to predict OA pro-
gression [5–8].
MRI texture analysis (MRI TA) has recently been de-
scribed as a method of quantifying subchondral bone changes
in OA which may offer superiority over existing biomarkers
[9]. MRI TA involves the calculation of several statistical
descriptors of image texture, aiming to characterise the het-
erogeneity and spatial-organisation of the subchondral bone.
The technique has been shown to be reproducible and able to
distinguish subjects at different stages of OA from healthy
subjects [9]. Moreover, texture features have shown an im-
proved ability to discriminate between knees with and without
OA when compared to microarchitectural analysis and are
significantly associated with histomorphometry [10, 11].
However, MRI TA has previously only been used to com-
pare subjects with OA and healthy controls. To be useful as a
prognostic or treatment evaluation imaging biomarker, it
should also be able to identify which individuals with OA
are likely to progress (predictive validity) and demonstrate
sensitivity to change for OA progression (concurrent validity).
Therefore, the purpose of this study was to evaluate wheth-
er (1) initial (i.e. OAI visit at 30 or 36 months) or (2) 12–18-
month change (i.e. between OAI visit at 30/36 months and 48
months) in MRI subchondral bone texture were predictive of
radiographic OA progression over 36 months (i.e. between
OAI visit at 36 months and 72 months).
Methods
The Osteoarthritis Initiative (OAI) has been approved by the
Institutional Review Boards of the University of California,
San Francisco and the four OAI clinical centers (University of
Pittsburgh, Ohio State University, University of Maryland,
Baltimore, and Memorial Hospital of Rhode Island). All par-
ticipants have given informed consent to participate in the
study. This was a retrospective nested case-control study.
The OAI datasets are freely available for download at
https://oai.epi-ucsf.org.
Subjects
Included participants were participants in the OAI Bone
Ancillary Study (BAS). The BAS featured 629 participants
who underwent MRI examination optimised for assessment
of subchondral bone in addition to the standard OAI MRI. All
BAS participants were members of the progression sub-co-
hort, participants with both frequent knee symptoms and ra-
diographic OA in at least one knee at OAI inception. Initial
trabecular bone MRIs were performed at either the 30- or 36-
month OAI visit, with the majority of participants undergoing
a repeat MRI at the 48-month OAI visit (B12–18-month fol-
low-up^). The study design is summarised in Fig. 1.
We defined study cases (Bprogressors^) as individuals with
radiographic progression over a 36-month period between the
36-month OAI visit and the 72-month OAI visit, according to
the definition of the Foundation for the National Institutes of
Health (FNIH) OA biomarkers consortium: a decrease in min-
imum medial tibiofemoral joint space width (minJSW) of ≥
0.7 mm, which has a less than 10% chance of being due to
measurement error [12]. The details of the radiographic acqui-
sition and assessments have been discussed in detail previous-
ly. Briefly, knee radiographs were performed using a non-
fluoroscopic fixed flexion technique [13]. Assessments in-
cluded central readings for Kellgren-Lawrence (KL) grading,
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Osteoarthritis Research Society International (OARSI) grad-
ing of joint space narrowing (JSN), measurement of
femorotibial alignment and automated measurement of joint
space width [14–16].
Progressors were matched to participants who did not have
radiographic progression between the 36-month OAI visit and
72-month OAI visit (controls) for age, sex, body mass index
(BMI) and initial medial minJSW in a 1:1 ratio, using an
optimal nearest-neighbour propensity score algorithm.
We excluded individuals who did not have measurements
of minJSWavailable at the 36-month or 72-month OAI visits
and individuals with KL grade-4 knees at the 36-month visit
(due to ceiling effects on minJSW progression in this group).
As this study focused on the medial tibiofemoral compart-
ment, we excluded any individuals who had lateral compart-
ment predominant disease at the 36-month OAI visit, as de-
fined by greater OARSI JSN grade in the lateral than medial
compartment.
MRI acquisition
Study participants were evaluated with a coronal-oblique
three-dimensional fast imaging with steady-state precession
(FISP) MRI sequence (field of view 12 x 12 cm, matrix 512
x 512 [interpolated to 1024 x 1024], slice thickness 1 mm,
repetition time 20 ms, echo time 4.92 ms, flip angle 50o, num-
ber of signal averages 1, acquisition time 10.5 minutes)
optimised for visualisation of subchondral trabecular bone
[17]. This was performed on one of four identical Siemens
Trio 3T MR platforms used for the OAI using a quadrature
transmit-receive knee coil (USA Instruments).
MRI analysis
The five most central coronal-oblique images through the cen-
tral medial tibiofemoral joint were identified with reference to
axial and sagittal reformats and used for subsequent analysis.
The MRI images were imported into a dedicated texture
analysis program (MazDA v3.3, freely available at http://
www.eletel.p.lodz.pl/programy/mazda/) [18]. Regions of
interest (ROIs) were created manually in the medial tibial
and medial femoral subchondral bone on each coronal im-
age by an analyst blinded to case or control status of par-
ticipants (JM, a musculoskeletal radiologist with 5 years’
experience). ROIs were defined superiorly and inferiorly
by the bone–cartilage interface, medially and laterally by
the margins of the tibial plateau and femoral condyle and
extended for a depth of approximately 1 cm into the
subchondral bone. Illustrative ROI examples are provided
in Fig. 2.
Nineteen texture features were calculated for each ROI
aiming to quantify the heterogeneity and spatial organisation
of the subchondral bone, according to the method described
previously [9]. These texture features belonged to one of four
classes: grey-level histogram, absolute gradient, run-length
matrix (RLM) and grey-level co-occurrence matrix
(GLCM). Briefly, grey-level histogram features are simple
descriptors of the distribution of grey levels (i.e. pixel intensity
values) in the ROI. Gradient, RLM and GLCM features are
higher-order descriptors of the spatial organisation of pixels in
the ROI. We used image compression settings of four bits/
pixel for calculation of gradient features, and six bits/pixel
for calculation of GLCM and RLM parameters. RLM param-
eters were calculated four times for each pixel (in the horizon-
tal, vertical, 45o and 135o directions) and GLCM parameters
Fig. 1 Study timeline for image assessments as part of the Osteoarthritis
Initiative
Fig. 2 Example coronal-oblique 3D FISP MR image demonstrating ROI
placement in the medial tibial (red) and medial femoral (green)
subchondral bone
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were calculated 20 times for each pixel at a variety of pixel
offsets ranging from 1 to 5 pixels. The mean value of each
RLM and GLCM parameter for each pixel in all possible
directions and pixel offsets was calculated for each coronal
image. The values of each texture parameter on each of the
five coronal images analysed were then averaged to give sum-
mary values in each participant for medial tibial and medial
femoral ROIs.
Texture analysis reproducibility
Twenty-three randomly selected participants were analysed in
duplicate by two independent analysts (JM & GK: both mus-
culoskeletal radiologists with 5 years’ experience) to assess
reproducibility. Analysts created ROIs independently and
were blinded to case or control status. The sample size was
based on previous data, suggesting a mean intraclass correla-
tion coefficient (ICC) value of 0.9 across texture features [10,
19]. Texture features with suboptimal reproducibility metrics
(ICCs of < 0.8 or root-mean-square average coefficient of
variation [RMSCV] of > 10% for either ROI) were excluded
from subsequent analyses.
Statistical analysis
Descriptive statistics for each texture feature were generated.
We compared the distribution of texture values in progressors
and controls visually using boxplots. We created composite
texture scores using linear combinations of texture features
with least absolute shrinkage and selection operator
(LASSO) penalised logistic regression. This helps to avoid
problems associated with overfitting when many predictor
variables are available by imposing a penalty for including
additional variables in a model. The LASSO model was cho-
sen based on minimisation of 10-fold cross-validation classi-
fication error. Because the folds for cross-validation are cho-
sen at random, the procedure was repeated with 100 iterations.
We used the logistic regression equation from the model iter-
ation giving the mean classification error to calculate a com-
posite texture score. This was performed separately for tibial,
femoral and combined (tibial and femoral) texture datasets
using initial MRI texture features and 12–18-month change
in MRI texture features.
Odds ratios were calculated for the increase or decrease in
odds of radiographic progression per one standard deviation
(SD) increase in texture score. The mean classification accu-
racy (c-statistic, equivalent to area under the receiver operat-
ing curve [AUC]) was recorded.
Inter-observer reproducibility was assessed using ICC
values (single measures, absolute agreement) and the
RMSCV for each texture feature.
All statistical analyses were performed using RStudio
version 1.0.136 for Mac, using the MatchIt package for
matching cases to controls, and the glmnet package for
performing LASSO regression [20, 21]. Statistical signifi-
cance of the logistic regression analyses was assessed using
the chi-squared test, with an adjusted p value threshold of <
0.008 to maintain an overall type 1 error rate of 0.05.
Results
Participants
Of 629 participants in the BAS, 359 were eligible for this
study following exclusions. Sixty-four participants met the
criterion for radiographic progression and were selected as
cases, with 64 controls matched for age, sex, BMI and initial
minJSW.
For initial timepoint analyses, 12 participants (3 cases)
were excluded due to excessive motion artefacts, defined
as preventing the identification of the bone–cartilage inter-
face (n = 5), unavailable initial MRI (n = 3) or large
subchondral cysts preventing ROI placement in trabecular
bone (n = 4). The matched controls for excluded cases
were also removed from the analysis. For each excluded
control, a new matched control was selected as the next
best match for the corresponding case according to the
matching algorithm.
For 12–18-month follow-up analyses, a further 17 partici-
pants were excluded due to excessive motion artefacts on
follow-up images (n = 8), unavailable follow-up MRI (n =
8), and surgical intervention during the interval between initial
and follow-up MRI (n = 1).
Initial and follow-up characteristics of included cases and
controls are presented in Table 1. A flow diagram for selection
of study participants is presented in Fig. 3.
Texture analysis reproducibility
Data for inter-observer reproducibility are presented in the
supplementary material. The majority of texture features dem-
onstrated excellent inter-observer reproducibility. Seven tex-
ture features were excluded from subsequent analyses at this
stage (per criteria in Methods), leaving a total of 12 texture
features for analysis.
Association of subchondral bone texture
and radiographic progression
Subchondral bone composite texture score was significant-
ly associated with 36-month radiographic progression
using the initial timepoint combined data (odds ratio
[95% confidence interval] = 1.84 [1.25 – 2.80], p =
0.002) and the 12–18-month change tibial (2.31 [1.42 –
4.12], p < 0.001), femoral (1.80 [1.17 – 2.92], p = 0.006)
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and combined (3.76 [2.04 – 7.82], p < 0.001) data.
Associations between subchondral bone texture score and
radiographic progression using initial timepoint tibial (1.43
[0.99 – 2.09], p = 0.06) and femoral (1.63 [1.12 – 2.44], p
= 0.009) data were not statistically significant. Results are
summarised in Table 2. Data for each individual texture
feature are provided in the supplementary material.
Example images are shown in Fig. 4.
Texture analysis classification
Combinations of both initial texture features and 12–18-
month change in texture features were able to predict radio-
graphic progression with statistical significance reached for
femoral and combined initial data, and tibial, femoral and
combined 12–18-month change data. The best classification
accuracy was demonstrated for combined 12–18-month
Fig. 3 Flow diagram for selection
of study participants
Table 1 Participant characteristics at initial timepoint and 12–18-month follow-up
Variable Initial 12–18-Month follow-up
Cases Controls Cases Controls
n = 61 n = 61 n = 53 n = 52
Age, yearsa 64 (49–81) 65 (48–82) 65 (50–82) 66 (49–83)
Sex, no. females 25 26 21 22
BMI, kg/m2 b 31.4 (4.7) 31.1 (4.7) 31.1 (4.5) 30.8 (4.6)
Time between baseline and follow-up MRI
(12/18 months)
– – 35/18 26/26
Initial minJSW, mmb 3.81 (1.20) 3.78 (1.19) 3.86 (1.19) 3.75 (1.20)
Kellgren Lawrence grade (0/1/2/3) 7/11/21/22 8/9/24/20 7/11/17/18 8/9/20/15
OARSI medial JSN grade (0/1/2) 17/22/22 23/18/20 15/20/18 21/16/15
OARSI lateral JSN grade (0/1/2) 60/1/0 58/3/0 52/1/0 50/2/0
Femorotibial alignment, degreesc –6.0 (1.9) –5.7 (2.1) –6.0 (1.8) –5.7(2.1)
minJSW change, mmb – – –1.29 (0.63) 0 (0.44)
aMean (range)
bMean (standard deviation)
cMean (standard deviation), negative values indicate varus alignment
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follow-up data with a c-statistic of 0.68 (95% confidence in-
terval 0.68 – 0.68, p < 0.001).
Classification performance is summarised in Table 2.
Discussion
This study demonstrates that combinations of initial and 12–
18-month change in subchondral bone MR texture features
are significantly associated with radiographic OA progression
over 36 months, with better predictive ability for 12–18-
month change data.
These results suggest that subchondral bone texture may
be a useful quantitative imaging biomarker for use in clin-
ical trials, particularly those with interventions targeting
subchondral bone. Although direct interpretation of the
texture scores used in this study is difficult, results are
consistent with progressors having less spatially organised,
more homogeneous subchondral bone at the initial
timepoint, and 12–18-month changes in the same direction.
This is supported by visual assessment of example images.
Combinations of texture features were able to predict case
and control status using both initial and 12–18-month
change in texture features. Classification accuracy im-
proved when tibial and femoral data were combined.
However, the best-performing model had only modest pre-
dictive ability (AUC 0.68), despite the strong associations
between texture score and radiographic progression.
Possible explanations for the limited performance of MR
subchondral bone texture in this study include a bias towards
advanced OA in our cohort, and the MRI sequence used.
First, as members of the progression sub-cohort of the OAI,
most participants had establishedOA.Our study sample was
further biased towardsmore advanced disease by the fact that
only individuals with established OA at the 48-month OAI
visit had quantitative JSW measurements performed at the
Table 2 Association between texture features and case vs. control status and classification performance
Region Initial 12–18-Month change
Odds ratio
(95% CI)a
Most important
featuresb
c-statistic
(95% CI)
Odds ratio
(95% CI)a
Most important
featuresb
c-statistic (95% CI)
Tibia 1.43 (0.99, 2.09) Gr. variance, variance 0.58 (0.58, 0.58) 2.31 (1.42, 4.12)*** Gr. mean, Gr. variance,
contrast
0.65 (0.63, 0.69)**
Femur 1.62 (1.12, 2.44)** Mean, variance, ASM 0.60 (0.59, 0.60)* 1.80 (1.17, 2.92)** ASM, contrast, variance 0.63 (0.61, 0.65)**
Combined 1.84 (1.25, 2.80)** F variance, F mean,
T variance
0.64 (0.64, 0.65)** 3.76 (2.04, 7.82)*** T Gr. variance, F ASM,
T entropy
0.68 (0.68, 0.68)***
T – tibial feature, F – femoral feature, Gr – gradient, ASM – angular second moment
* p < 0.05, ** p < 0.01, ***p < 0.001
aOdds ratio of being a progressor for each o standard deviation increase in texture score
b Three texture features with largest standardised coefficients (β) in the logistic regression model (note initial tibial model only included two texture features)
Fig. 4 Example coronal 3D FISP
MR images through the medial
tibiofemoral compartment of
radiographic progressors and non-
progressors at the initial
timepoint. A, non-progressor,
texture score (TS) –1.22, B, non-
progressor, TS –1.44, C,
progressor, TS +1.01, and D,
progressor, TS +0.93. Higher
texture scores correspond to less
spatially organised subchondral
bone
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72-month OAI visit. MR subchondral bone texture has pre-
viously demonstrated the ability to detect relatively early
OA-related changes in the subchondral bone; therefore, it
may be that it is of less use in more established disease.
Second, the MRI sequence used as part of the OAI BAS
was optimised for analysing trabecular microarchitecture
(i.e. direct estimation of histomorphometry parameters).
While texture analysis has previously been described using
a similar MRI sequence, it has also been demonstrated that
alternative MRI sequences may provide improved texture
discrimination between groups [22].
Nevertheless, the strength of association between texture
scores and radiographic progression and the AUC values pre-
sented here are competitive when compared to several alter-
native OA imaging biomarkers, especially considering the
relatively short follow-up time and matching of the control
cohort in this study for important predictive covariates of
age, sex and BMI [5, 23–26]. For example, in the FNIH OA
biomarkers consortium studies, central medial tibiofemoral
compartment cartilage loss over 24 months was associated
with radiographic progression at 24–28 months with a similar
odds ratio (3.8 [95% CI 2.7 to 5.5]) to that for 12–18-month
change in combined texture score (3.8 [2.0 – 7.8]) in this study
[25]. In the same FNIH cohort, associations between femoral
bone shape change (odds ratio 2.7 [2.0 to 3.6]) and femoral
bone area change (2.9 [2.1 to 3.9]) over 24 months and radio-
graphic progression at 24-48 months were also of a similar
magnitude to those described here [26]. Associations between
fractal signature analysis (FSA) parameters obtained from
plain radiographs and radiographic progression in the FNIH
OA biomarkers cohort were weaker than those described in
this study, as was the predictive ability of FSA [5].
Our results demonstrate that MRI TA of subchondral bone
can be considered a useful addition to the suite of imaging
biomarkers available for further OA imaging research studies.
One advantage over alternative techniques is the multidimen-
sional data output of texture analysis, which is well-placed to
interact with machine-learning-based approaches to image in-
terpretation. Indeed, the LASSO method employed here is an
example of such an approach.
One disadvantage of MRI TA is that it is not always clear
what the biological or structural correlates of individual
texture features are, despite previous demonstration of as-
sociation with histomorphometry [11]. However, as has
been shown by the use of texture analysis in imaging appli-
cations other than assessment of subchondral bone, this lack
of correspondence to an underlying structural ‘ground-
truth’ does not preclude the use of this method to improve
our understanding of the underlying disease process
[27–29]. In the present study, MRI TA has usefully quanti-
fied the degree of ‘abnormality’ in the appearance of the
subchondral bone despite limited structural correlation of
the texture parameters used.
Future work could evaluate MRI TA of subchondral bone
in alternative populations, and a head-to-head comparison of
different methods for analysing subchondral bone would help
to determine the optimal imaging biomarker for use in clinical
trials. A barrier to performing this comparison in the present
study was the fact that the platforms used for several alterna-
tive methods are not freely available, in contrast to the method
used here. Automation of the time-consuming ROI-drawing
procedure would also encourage wider use of this method.
There are several limitations to the present study. Structural
correlates for texture parameters have been assessed in previ-
ous studies, but using a differentMRI sequence. Nevertheless,
a comparison of texture features between sequences has
shown similar changes in both, so it is reasonable to assume
similar structural correlates for the texture features derived
from the MRI sequence used in this study [22]. We used a
retrospective case-control design which is subject to selection
bias. However, our matching process ensured that cases and
controls were well-matched for important baseline character-
istics. In common with other longitudinal studies using the
OAI dataset, it is not possible to completely separate concur-
rent from predictive validity for MR subchondral bone texture
as the period of follow-up for change in MR texture features
overlapped with the follow-up period for radiographic pro-
gression. We had a small sample size for the number of texture
features analyzed which risks introducing bias into any clas-
sification procedure. We have aimed to minimise this by ex-
cluding texture features with poor reproducibility, using cross-
validation, and using penalised regression to limit the number
of texture features incorporated into our classification models.
Finally, we defined OA progression based on change in radio-
graphic joint space width. This measure is established and
robust but captures only one aspect of OA progression.
Symptomatic progression is also important, but not consid-
ered in this study due to the low numbers of symptomatic
progressors in our cohort.
In conclusion, initial and 12–18-month change in com-
binations of MR subchondral bone texture features were
associated with 36-month radiographic OA progression,
with better predictive performance of 12–18-month change
data.
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